RN
Therapeutic Areas
Lucy Scientific Discovery Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lucy 1.0 (Psilocybin) | Mental Health Disorders (e.g., Depression, Anxiety) | Pre-clinical |
| Lucy 2.0 (Novel Psilocybin Analog) | Mental Health Disorders | Discovery |
| Lucy 3.0 (Novel MDMA Analog) | Mental Health & Addiction Disorders | Discovery |
| Cannabinoid-based Formulations | Chronic Pain, Neurological Conditions | Pre-clinical |